Diagnosis and management of patients with the antiphospholipid syndrome

Journal of Thrombosis and Thrombolysis

Volumn 12, Issue 1, 2001, Pages 89-93

  Alving, B M ^a  

^a NATIONAL HEART LUNG AND BLOOD INSTITUTE   (United States)

Author keywords

Anticardiolipin antibodies; Antiphospholipid syndrome; Lupus anticoagulant

Indexed keywords

ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; AZATHIOPRINE; BETA2 GLYCOPROTEIN 1; CARDIOLIPIN; CARDIOLIPIN ANTIBODY; CORTICOSTEROID; HEPARIN; IMMUNOSUPPRESSIVE AGENT; LOW MOLECULAR WEIGHT HEPARIN; LUPUS ANTICOAGULANT; PHOSPHOLIPID; PHOSPHOLIPID ANTIBODY; PHOSPHOLIPID BINDING PROTEIN; PREDNISONE; PROTHROMBIN; WARFARIN;

ANTICOAGULATION; ANTIPHOSPHOLIPID SYNDROME; ARTERY THROMBOSIS; AUTOIMMUNE DISEASE; BLOOD CLOTTING TEST; BODY WEIGHT DISORDER; CLINICAL FEATURE; CLINICAL TRIAL; CONFERENCE PAPER; CONNECTIVE TISSUE DISEASE; DIABETES MELLITUS; DISEASE ASSOCIATION; DRUG METABOLISM; ENZYME LINKED IMMUNOSORBENT ASSAY; FETUS WASTAGE; HUMAN; HYPERTENSION; LABORATORY TEST; META ANALYSIS; METABOLIC DISORDER; PLASMAPHERESIS; PREGNANCY; PRIORITY JOURNAL; PROTHROMBIN DEFICIENCY; RECURRENT ABORTION; RECURRENT DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS; THROMBOCYTOPENIA; TREATMENT OUTCOME; VEIN THROMBOSIS;

ANTIBODIES, ANTIPHOSPHOLIPID; ANTICOAGULANTS; ANTIPHOSPHOLIPID SYNDROME; FEMALE; FETAL DEATH; HUMANS; LUPUS COAGULATION INHIBITOR; MALE; PREGNANCY; THROMBOSIS;

EID: 0035184969     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012798713607     Document Type: Conference Paper

References (24)

1. The anticardiolipin syndrome
2. Antiphospholipid antibodies and thrombosis
3. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome
4. Anticardiolipin antibodies: Detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus
5. The relationship of anti-phospholipid antibodies to thromboembolic disease in systemic lupus erythematosus: A cross-sectional study
6. Antiphospholipid antibodies: Anticardiolipin and the lupus anticoagulant in systemic lupus erythematosus (SLE) and in non-SLE disorders
7. Cerebrovascular and neurologic disease associated with antiphospholipid antibodies: 48 cases
8. Lupus anticoagulant and anticardiolipin antibodies in young adults with cerebral ischemia
9. Criteria for antiphospholipid syndrome: Early pregnancy loss, fetal loss, or recurrent pregnancy loss?
10. Randomised controlled trial of aspirin and aspirin plus heparin in pregnant women with recurrent miscarriage associated with phospholipid antibodies (or antiphospholipid antibodies)
11. Repeated fetal losses associated with antiphospholipid antibodies: A collaborative randomized trial comparing prednisone with low-dose heparin treatment
12. A clinical trial for the treatment of antiphospholipid-antibody associated recurrent pregnancy loss with lower dose aspirin and heparin
13. Safety of low-molecular-weight heparin in pregnancy: A systematic review
14. Treatment of antiphospholipid syndrome in pregnancy
15. Use of antithrombotic agents during pregnancy
16. Antiphospholipid antibody-mediated disruption of the annexin-V antithrombotic shield: A thrombogenic mechanism for the antiphospholipid syndrome
17. Thrombocytopenia in SLE and related autoimmune disorders: Association with anticardiolipin antibody
18. Anticardiolipin antibodies in autoimmune thrombocytopenic purpura
19. Prevalence and clinical significance of elevated antiphospholipid antibodies in patients with idiopathic thrombocytopenic purpura
20. The management of thrombosis in the antiphospholipid-antibody syndrome
21. Antiphospholipid antibodies and venous thromboembolism
22. Monitoring warfarin therapy in patients with lupus anticoagulants
23. Control of oral anticoagulation in patients with the antiphospholipid syndrome - Influence of the lupus anticoagulant on international normalized ratio
24. The catastrophic antiphospholipid syndrome 1996: Acute multi-organ failure associated with antiphospholipid antibodies: A review of 31 patients